Trojan Horse of Measles—More Vaccines With the Mandate
Opinion | Bills to either remove or restrict vaccine exemptions have been filed across the U.S. in 2019. One of the most striking was New York’s A2371, which eliminated the religious exemption to vaccination in one day, with no public hearings. Soon after, New York state health officials eliminated the ability of doctors to grant medical […]
Illinois Mandates Insurance Coverage for EpiPens
Illinois has become the first state to pass a law requiring health insurance companies to cover the cost of medically necessary EpiPen injectors. This is big news in an era when so many families face the daily threat of a potentially deadly allergic reaction. Signed by Governor J.B. Pritzker, the new law will take effect […]
Novartis Manipulated Data in FDA Biologics License Application
On Aug. 6, 2019, the U.S. Food and Drug Administration (FDA) issued a statement saying that Swiss pharmaceutical company Novartis AG submitted a biologics license application (BLA) for the spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec-xioi) with manipulated data and failed to inform regulators until June 28, 2019—more than a month after the […]
Pfizer Fined Again for Violating Drug Laws
Colombia’s national regulatory agency, the Superintendency of Industry and Commerce (SIC), has fined pharmaceutical company Pfizer $25,000 for allegedly inflating the price of several prescription drugs it sold in that country.1 2 On July 31, 2019, the agency stated: The decision was taken after verifying information related to PFIZER SAS’ commercial operations between July and December […]
Is Merck’s Measles Vaccine Monopoly a Cause for Concern?
First, how did Merck become the country’s sole supplier of these measles vaccines, and is that a problem? Well, is it a problem depends on who you talk to. But Merck became the sole supplier because the vaccine market is highly concentrated. It’s incredibly expensive to make vaccines. It takes a lot of time to […]
MMR Vaccine Sales Boost Merck’s 2019 Revenues
After the Centers for Disease Control and Prevention (CDC) publicized measles outbreaks in several states beginning in January 2019, on May 1 Merck & Co. announced that it had increased production of its live attenuated (weakened) virus MMR (measles, mumps, rubella) vaccine in response to an increasing demand for the product in the United States. […]